Position
Fidelity in Mirum Pharmaceuticals, Inc.
Back to the book · All holders of MIRM
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $275.1M$23.60 → $62.44
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 6.7M | $66.7M | — | — | — | 0.0% |
| Q1 2026 | 8.52M | $201.1M | $23.60 | $91.5M | $42.9M | 0.0% |
| Q2 2026 | 7.08M | $442.3M | $62.44 | $275.1M | −$33.9M | 0.0% |